30.950
−0,16%
2026-10-19
Fundamental Analysis
24 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -58.6% | -94.7% | 1 / 3 | +54.1% | -6.61 pp | -10.20 pp | +2.2% | 1.43 | 121.92 | 2.137 | +54,1% | 105 | −50,0% | 121.92 | 27.03 | +351,1% |
| Pts | 0 | 0 | 4 | 12 | 0 | 0 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 30.950 (close price on 2026-10-19)EPS (TTM): 253,9
Financial charts
1.Revenue & growth
VND bn2.137Q2/26
1.Revenue & growth
VND bn2.137Q2/26
2.Profit & growth
VND bn104Q2/26
3.Profit mix (Penman)
VND bn68,2Q2/26
4.Margins & cost structure
%13.6%Q2/26
5.Returns & cash cycle
% · days0.8%Q2/26
6.Earnings quality & cash
VND bn-955Q2/26
7.Asset structure
VND bn13.516Q2/26
8.Funding & debt health
VND bn · times13.516Q2/26
9.Revenue backlog
VND bn6,95Q2/26
10.Valuation
times · %119,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %344Q2/26
Adjusted EPS growth, latest quarter
-50.3%
Average adjusted EPS growth, 3 quarters
-107%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26